This company has shut down. Pyros Pharmaceuticals is no longer operating — its last tracked round was a Seed in 2022.
Explore the Startup GraveyardPyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.
Pyros Pharmaceuticals has raised $450K in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Pyros Pharmaceuticals is headquartered in New York, United States.
Pyros Pharmaceuticals is a generic drug company dedicated to developing and commercializing low-cost generics.
Pyros Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pyros Pharmaceuticals — Funding & Investors." VCBacked, April 4, 2022, https://www.vcbacked.co/company/pyros-pharmaceuticals. Accessed August 14, 2026.
VCBacked. (2022). Pyros Pharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/pyros-pharmaceuticals
{{cite web |title=Pyros Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/pyros-pharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated